期刊文献+

革兰阴性杆菌产超广谱β-内酰胺酶头孢菌素酶状况及耐药性研究 被引量:2

Study on antimicrobial resistance and detection of extended-spectrum β-lactamases-producing and AmpC producing strains in Gram-negative bacili
下载PDF
导出
摘要 目的了解本院目前常见的革兰阴性杆菌菌种分布及产超广谱β-内酰胺酶(ESBLs)和头孢菌素酶(AmpC)情况,分析产酶菌耐药谱特征。方法用法国生物梅里埃公司的VITEK-2细菌鉴定与药敏系统对革兰阴性杆菌进行鉴定,对可疑产ESBLs、AmpC的菌株,用标准纸片扩散法和三维试验法进行两种酶的表型确证,再用纸片扩散法行药物敏感性检测。结果检出单产ESBLs、单产AmpC、同时产ESBLs和AmpC的细菌分别为175株(43.8%)、54株(13.5%)和28株(7.0%)。ESBLs检出率以肺炎克雷伯菌最高,为60.3%;AmpC检出率在阴沟肠杆菌中最高,为46.7%。单产ESBLs菌株对亚胺培南、头孢哌酮/舒巴坦以及哌拉西林/三唑巴坦的敏感性较高,耐药率分别为2.3%、26.3%和33.1%;单产AmpC菌株对亚胺培南和头孢吡肟具有较高的敏感性,耐药率分别为3.7%和29.6%;同时产AmpC和ESBLs的菌株仅对亚胺培南敏感,未发现耐药株。结论革兰阴性杆菌产ES-BLs、AmpC率较高,该类菌对大多数新型广谱β-内酰胺类抗生素耐药,对亚胺培南敏感。 Objective To investigate the strains distribution of common Gram-bacterial bacilli and the preva- lence of extended-spectrum β-1actamases(ESBLs) and AmpC- producing Gram-negative bacteria form our hospital, and to analyze their characteristics of drug resistance spectra. Methods Gram-negative bacteria were identified with VITEK-2 and the drug sensitivity system, suspected ESBLs-isolates were identified with the method recommended by the National Committee for Clinical Laboratory Standard(NCCLS). AmpC- producing and AmpC-producing com- bined with ESBLs-producing strains were detected by three-dimensional test. The antimicrobial susceptibility of AmpC-producing and ESBLs-producing strains were detected by Kirby-Bauer methods. Results ESBLs,AmpC-pro- ducing and AmpC-producing combined with ESBLs-producing strains were found in 175 starins (43.8%),54 strains (13. 5%) and 28 strains (7.0%) respectively. Among ESBLs-producing strains, the most common isolates were Klebsiella pneumoniae(60.3% )and Escherichia coli(49.2 % ). The most common AmpC-producing strains was Enter- obacter cloacae (46.7% ). The AmpC-producing strains were more susceptible to imipenem and cefepime,its resistant rates were 3.7% and 29.6% respectively. The resistant rates of ESgLs-producing strains to imipenem, eefopera- zone/sulbaetam piperacillin/sulbactam and were 2.3%, 26.3 % and 29.6 % respectively. AmpC-producing combined with ESBLs-producing strains were only sensitive to imipenem, imipenem-resistant strain was not found. Conclusion ESBLs-produeing and AmpC-producing gram-negative strains are common in clinical isolates from hospi- tal,and resistant to the majority of new broad spectrum β-lactamas,but sensitive to imipenern.
作者 唐劲松
出处 《检验医学与临床》 CAS 2012年第7期804-806,共3页 Laboratory Medicine and Clinic
关键词 革兰阴性杆菌 超广谱Β-内酰胺酶 头孢菌素酶 耐药性 gram-negative bacteria extended-spectrum β-lactamases AmpC-producing drug resistance
  • 相关文献

参考文献9

二级参考文献42

共引文献98

同被引文献43

  • 1杨启文,徐英春.诱导型AmpC酶和结构型AmpC酶的检测与产酶菌株感染的治疗进展[J].中华检验医学杂志,2005,28(4):457-460. 被引量:17
  • 2陈民钧,俞云松,王辉,徐英春.改进药敏折点标准 指导临床合理选择抗菌药物[J].中华检验医学杂志,2005,28(6):565-568. 被引量:17
  • 3刘晶,多丽波.染色体介导的AmpC酶研究进展[J].国际检验医学杂志,2006,27(7):641-643. 被引量:13
  • 4Bedenic B, Beader N, Zagar Z. Effect of inoculum size on theanti*bacterial activity of cefpirome and cefepime against Klebsiellapneu-moniae strains producing SHV extended spectrum beta lactamases[J]. ClinMicrobiol Infect, 2001,7 (11) =626-635. 被引量:1
  • 5Joshua PM,John HP, Michael ND,et al. Antimicrobial Drug Resist-ance, Regulation, and Research [ J ]. Emerg Infect Dis, 2006 12(2):183-190. 被引量:1
  • 6Bush K,Jacoby GA,Medeiros AA. Afunctional classification schemefor beta-lactamases and its correlation withmolecular structure [ J].Antimicrob Agents Chemother, 1995 ,39(6) :1211-1233. 被引量:1
  • 7Ding H, Yang Y, Lu Q, et al. The prevalence of plasmid-mediatedAmpC beta-lactemases among clinical isolates of Escherichia coli andklebsiella pneuminae from five children ’ s hospitals in China [ J ].Eur J Clin Microbiol Infect Dis, 2008,27(10) :915-921. 被引量:1
  • 8Pfaller MA, Jones RN. Antimicrobial susceptibility of inducible AmpC beta-lactamase-producing Enterobacteriaceae from theMero- penem Yearly Susceptibility Test Information Collection (MYSTIC) Programme, Europe 1997-2000[ J]. Int J Antimicrob Agents,2002, 19(5) :383-388. 被引量:1
  • 9Kumarasamy KK, Toleman MA, Walsh TR, et al. Emergence of anew antibiotic resistance mechanism in India,Pakistan, and theUK: a molecular, biological and epidemiological study[ J]. LancetInfect Dis, 2010,10( 9) :597-602. 被引量:1
  • 10Kelesidis T,Karageorgopoulos DE,Kelesidis I,et al. Tigecycline forthe treatment of multidrug-resistant Enterobacteriaceae : a systemat-ic review of the evidence from microbiological and clinical studies[J]. J Antimicrob Chemother,2008,62(5) :895-904. 被引量:1

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部